ArticleFrontiers in immunology2022

Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines.

Nicolas Çuburu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.